FDA
-
-
-
-
-
-
-
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium
-
-
-
-
-
-
-
FSD Pharma Announces Filing of Criminal Complaint Against Former Chief Financial Officer
-
-
-
-
-
-
-
FSD Pharma Announces Appointment of Interim Chief Financial Officer
-
-
-
-
-
-
-
Cofttek, China's Largest Manufacturer of PEA, Draws Attention of Investors
-
-
-
-
-
-
-
FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
-
-
-
-
-
-
-
FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc.
-
249,538 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All